10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Navidea Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the ...

After more than a decade of development and a couple regulatory delays, Navidea Biopharmaceuticals (NYSE:NAVB) finally got the FDA approval it needs to begin marketing its radiopharmaceutical ...

Navidea Biopharmaceuticals Announces Opening of Nine New Sites in its Pivotal Phase 3 Trial in Rheumatoid Arthritis and Termination of Binding Memorandum of Understanding with Jubilant Radiopharma ...

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB) Q3 2022 Earnings Call Transcript November 15, 2022 Operator: Greetings and welcome to the Navidea Biopharmaceuticals’ Quarter Three Earnings Call and ...

Navidea Biopharmaceuticals Inc. NAVB announced Friday that it had rejected an unsolicited ProPhase Labs Inc. PRPH offer for certain Navidea assets, saying the proposal undervalues Navidea and is not ...

Although shares of Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) are relatively unchanged over the trailing-12-month period, ask shareholders and they’d probably consider Navidea’s performance a ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Navidea Biopharmaceuticals Inc. CEO Mark Pykett takes an 8.9 percent salary reduction as part of a new 21-month employment agreement, in line with a December vote by company directors to cut pay for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.